Clinical trial
The Assessment of the Minimal Effective and Tolerated Dose of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders
NCT00904709 is registered in ClinicalTrials.gov with K. Sue Robinson as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Assessment of the Minimal Effective and Tolerated Dose of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders
- Lead sponsor
- K. Sue Robinson
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 19, 2009
- Completion date
- March 1, 2014
- Enrollment
- 249 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.